Stay updated with breaking news from Recent Operational. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.08.2022 - -First Patient Treated in HOPE-3, the Pivotal Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy- -Positive One-Year Safety and Efficacy Results From HOPE-2 Open Label Extension Study of CAP-1002 in Non-Ambulant ...
Company Issues Shareholder Letter Vertical Aerospace Ltd. ("Vertical" or the "Company") (NYSE: EVTL; EVTLW), a global aerospace and technology company that is pioneering zero emission aviation, announces
Completed dose-escalation portion of the ongoing Phase 1 study of NTLA-2001 in patients with transthyretin amyloidosis with cardiomyopathy; expects to present interim safety and serum TTR reduction... | August 4, 2022
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...